Learn more

BAIYAO ZHIDA BEIJING NANO BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    11
  • GoodIP Patent Rank
    156,619
About

BAIYAO ZHIDA BEIJING NANO BIOTECHNOLOGY CO LTD has a total of 11 patent applications. Its first patent ever was published in 2019. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals are LICONSA LIBERACION CONTROLADA, LEADING BIOSCIENCES INC and HAOMAMEDICA LTD.

Patent filings in countries

World map showing BAIYAO ZHIDA BEIJING NANO BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 11

Patent filings per year

Chart showing BAIYAO ZHIDA BEIJING NANO BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Wang Liyuan 11
#2 Wang Meng 11

Latest patents

Publication Filing date Title
CN111053913A Cytarabine-containing medicine, preparation method thereof, pharmaceutical composition and application
CN111097051A Medicine containing vincristine, preparation method thereof, medicine composition and application thereof
CN111068065A Drug containing oxaliplatin, preparation method thereof, pharmaceutical composition and application thereof
CN111053915A Lenalidomide-containing medicine, preparation method thereof, medicine composition and application
CN111053914A Mitoxantrone-containing medicament, preparation method thereof, pharmaceutical composition and application thereof
CN111084887A Flavone-containing medicine, preparation method thereof, medicine composition and application
CN111096965A Medicine containing dihydroartemisinin, preparation method thereof, medicine composition and application thereof
CN111053919A Medicine containing idarubicin, preparation method thereof, pharmaceutical composition and application thereof
CN111053765A Medicine containing paclitaxel, preparation method thereof, pharmaceutical composition and application
CN110711253A Medicine containing adriamycin and preparation method thereof
CN110711254A Nucleic acid nanoparticles and pharmaceutical compositions comprising the same